+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biomaterials Market Report and Forecast 2023-2031

  • PDF Icon

    Report

  • 147 Pages
  • April 2023
  • Region: Global
  • Expert Market Research
  • ID: 5797876
Description Jump to:
The global biomaterial market size attained a value of USD 130.8 billion in 2022. The market is likely to grow further at a CAGR of 14.10% during the forecast period of 2023-2031 to attain a value of USD 429.9 billion by 2031.

Biomaterial Market: Introduction

Biomaterials are natural or synthetic materials designed to interact with biological systems for various therapeutic or diagnostic purposes. They play a crucial role in diverse fields such as tissue engineering, regenerative medicine, drug delivery, and medical devices. These materials have unique properties that allow them to mimic the natural environment of cells and tissues, ensuring biocompatibility and safety for use in the human body.

Some common uses of biomaterials include the creation of artificial organs, joint replacements, stents, dental implants, and wound healing products. Additionally, they are employed in the controlled release of drugs, providing targeted and sustained delivery of therapeutic agents. Overall, biomaterials have revolutionized healthcare, enhancing patient outcomes, and improving overall quality of life.

Biomaterial Market Segmentations

The market can be categorised into product, application, and major region.

Market Breakup by Product

  • Natural Biomaterial
  • Metallic Biomaterial
  • Ceramic Biomaterial
  • Polymeric Biomaterial

Market Breakup by Application

  • Neurology
  • Neural stem cell encapsulation
  • Shunting systems
  • Hydrogel scaffold
  • Cortical neural prosthetics
  • Others
  • Cardiology
  • Sensors
  • Stents
  • Implantable Cardiac defibrillators
  • Pacemakers
  • Vascular graft Market
  • Others
  • Orthopaedics
  • Joint Replacement Biomaterials
  • Orthobiologics
  • Bio-resorbable tissue fixation products
  • Viscosupplementation
  • Spine Biomaterials
  • Others
  • Ophthalmology
  • Synthetic Corneas
  • Intraocular Lens Market
  • Contact Lens
  • Ocular tissue replacement
  • Others
  • Wound Care
  • Fracture Healing Device
  • Adhesion Barrier
  • Skin Substitute
  • Internal Tissue Sealant
  • Surgical Haemostats
  • Others
  • Dental
  • Tissue Regeneration Material
  • Dental Implants
  • Bone Grafts and Substitutes
  • Dental Membranes
  • Others
  • Plastic Surgery
  • Facial Wrinkle Treatment
  • Soft Tissue Fillers
  • Craniofacial Surgery
  • Bioengineered skins
  • Peripheral nerve repair
  • Acellular dermal matrices
  • Others
  • Others

Biomaterial Market Breakup by Region

North America

  • United States of America
  • Canada

Europe

  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Biomaterial Market Scenario

The biomaterials market has witnessed significant growth in recent years, driven by advancements in material science, increasing demand for medical implants, and a growing aging population with a heightened need for healthcare solutions. This global market encompasses a wide range of materials, including metals, ceramics, polymers, and natural materials, catering to diverse applications in orthopaedics, cardiovascular, dental, ophthalmology, and wound care, among others.

Moreover, ongoing research and development efforts are leading to the emergence of novel biomaterials with enhanced biocompatibility and functionality. As a result, the biomaterials market is expected to continue expanding at a robust pace, presenting lucrative opportunities for both established players and new entrants in the field.

Key Players in the Global Biomaterial Market

The report gives an in-depth analysis of the key players involved in the biomaterial market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
  • Koninklijke DSM N.V
  • Corbion N.V
  • Zimmer Biomet
  • Noble Biomaterials Inc
  • Bayer AG
  • Berkeley Advanced Biomaterials
  • Evonik Industries AG
  • CAM Bioceramics B.V
  • Grifols, S.A
  • Invibio Ltd
  • BASF SE
  • Zimmer Biomet Holdings, Inc
  • Pfizer Inc, Alkermes
  • Covalon Technologies Ltd
  • Collagen Matrix, Inc
  • Corbion

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Biomaterial Market Overview
3.1 Global Biomaterial Market Historical Value (2016-2022)
3.2 Global Biomaterial Market Forecast Value (2023-2031)
4 Global Biomaterial Market Landscape
4.1 Global Biomaterial Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Biomaterial Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Region
4.2.3 Analysis by Applications
5 Global Biomaterial Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Biomaterial Market Segmentation
6.1 Global Biomaterial Market by Product
6.1.1 Market Overview
6.1.2 Natural Biomaterial
6.1.3 Metallic Biomaterial
6.1.4 Ceramic Biomaterial
6.1.5 Polymeric Biomaterial
6.2 Global Biomaterial Market by Application
6.2.1 Market Overview
6.2.2 Neurology
6.2.2.1 Neural stem cell encapsulation
6.2.2.2 Shunting systems
6.2.2.3 Hydrogel scaffold
6.2.2.4 Cortical neural prosthetics
6.2.2.5 Others
6.2.3 Cardiology
6.2.3.1 Sensors
6.2.3.2 Stents
6.2.3.3 Implantable Cardiac defibrillators
6.2.3.4 Pacemakers
6.2.3.5 Vascular graft Market
6.2.3.6 Others
6.2.4 Orthopedics
6.2.4.1 Joint Replacement Biomaterials
6.2.4.2 Orthobiologics
6.2.4.3 Bio-resorbable tissue fixation products
6.2.4.4 Viscosupplementation
6.2.4.5 Spine Biomaterials
6.2.4.6 Others
6.2.5 Ophthalmology
6.2.5.1 Synthetic Corneas
6.2.5.2 Intraocular Lens Market
6.2.5.3 Contact Lens
6.2.5.4 Ocular tissue replacement
6.2.5.5 Others
6.2.6 Wound Care
6.2.6.1 Fracture Healing Device
6.2.6.2 Adhesion Barrier
6.2.6.3 Skin Substitute
6.2.6.4 Internal Tissue Sealant
6.2.6.5 Surgical Hemostats
6.2.6.6 Others
6.2.7 Dental
6.2.7.1 Tissue Regeneration Material
6.2.7.2 Dental Implants
6.2.7.3 Bone Grafts and Substitutes
6.2.7.4 Dental Membranes
6.2.7.5 Others
6.2.8 Plastic Surgery
6.2.8.1 Facial Wrinkle Treatment
6.2.8.2 Soft Tissue Fillers
6.2.8.3 Craniofacial Surgery
6.2.8.4 Bioengineered skins
6.2.8.5 Peripheral nerve repair
6.2.8.6 Acellular dermal matrices
6.2.8.7 Others
6.2.9 Others
6.3 Global Biomaterial Market by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Biomaterial Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Biomaterial Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Biomaterial Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Biomaterial Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Biomaterial Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Koninklijke DSM N.V.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Corbion N.V.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Zimmer Biomet
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Noble Biomaterials Inc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Bayer AG
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Berkeley Advanced Biomaterials
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Evonik Industries AG
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 CAM Bioceramics B.V.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Carpenter Technology Corporation
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Grifols, S.A.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Invibio Ltd.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 BASF SE
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Zimmer Biomet Holdings, Inc.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Pfizer Inc, Alkermes
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Covalon Technologies Ltd.
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 Collagen Matrix, Inc.
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
17.17 Corbion
17.17.1 Financial Analysis
17.17.2 Product Portfolio
17.17.3 Demographic Reach and Achievements
17.17.4 Mergers and Acquisitions
17.17.5 Certifications
18 Global Biomaterial Market- Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Koninklijke Dsm N.V.
  • Corbion N.V.
  • Zimmer Biomet
  • Noble Biomaterials Inc.
  • Bayer AG
  • Berkeley Advanced Biomaterials
  • Evonik Industries AG
  • Cam Bioceramics B.V.
  • Carpenter Technology Corporation
  • Grifols, S.A.
  • Invibio Ltd.
  • Basf Se
  • Zimmer Biomet Holdings, Inc.
  • Pfizer Inc, Alkermes
  • Covalon Technologies Ltd.
  • Collagen Matrix, Inc.
  • Corbion

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages147
PublishedApril 2023
Forecast Period2023 - 2031
Estimated Market Value ( USD ) in 2023 $ 149.2 Billion
Forecasted Market Value ( USD ) by 2031 $ 429.9 Billion
Compound Annual Growth Rate14.1%
Regions CoveredGlobal
No. of Companies Mentioned17

Related Topics

Related Reports

Biomaterials Market by Type, Classification, Application - Global Forecast 2025-2030 - Product Image

Biomaterials Market by Type, Classification, Application - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Biomaterials - Global Strategic Business Report - Product Image

Biomaterials - Global Strategic Business Report

  • Report
  • 134 Pages
  • Global
From
Bio Implants Market Report and Forecast 2024-2032 - Product Image

Bio Implants Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From
Orthopaedic Biomaterials Market Report and Forecast 2024-2032 - Product Image

Orthopaedic Biomaterials Market Report and Forecast 2024-2032

  • Report
  • 165 Pages
  • Global
From
Biomaterials Market Report by Type, Application, and Region 2024-2032 - Product Image

Biomaterials Market Report by Type, Application, and Region 2024-2032

  • Report
  • 140 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.